# Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department

> **NCT06085937** · PHASE1 · RECRUITING · sponsor: **Lindsay Maguire, MD** · enrollment: 50 (estimated)

## Conditions studied

- Suicide
- Suicidal Ideation
- Depression

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT06085937
- **Lead sponsor:** Lindsay Maguire, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2026-04
- **Final completion:** 2027-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06085937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06085937, "Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06085937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*